NCT05130424Unknown不适用
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
SuxiaLuo1 个研究点 分布在 1 个国家目标入组 498 人开始时间: 2021年9月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 498
- 试验地点
- 1
- 主要终点
- Incidence of adverse events after the treatment of Herombopag
研究概览
简要总结
To observe and evaluate the safety and effectiveness of herombopag in the treatment of thrombocytopenia-related diseases in Henan Province
详细描述
This study is designed as a real-world study on the treatment of thrombocytopenia-related diseases with Herombopag, to observe and analyze the safety and efficacy of Herombopag for thrombocytopenia-related diseases in the real world.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Thrombocytopenia related diseases;
- •Volunteer to join this study and sign an informed consent form;
- •Clinical evaluation can benefit from Herombopag.
排除标准
- •Those who have been confirmed to be allergic to Herombopag and/or its excipients;
- •Pregnant or breastfeeding women;
- •Except for patients with contraindications to Herombopag;
- •Doctors evaluate patients who are not suitable for inclusion.
结局指标
主要结局
Incidence of adverse events after the treatment of Herombopag
时间窗: From the treatment of Herombopag to 28 days after the end of the medication
The investigator will observe incidence of adverse events after the treatment of Herombopag, including thrombosis, diarrhea, abnormal liver function and so on.
次要结局
- Changes of the platelet counts after the treatment of Herombopag(From the treatment of Herombopag to 28 days after the end of the medication)
- Proportion of patients with platelet transfusion(From the treatment of Herombopag to 28 days after the end of the medication)
研究者
SuxiaLuo
chief physician
Henan Cancer Hospital
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTStem Cell Transplant ComplicationsThrombocytopeniaNCT06202625Peking University People's Hospital142
Unknown
2 期
A Clinical Study of Herombopag in Tumors-associated ThrombocytopeniaTumor Therapy-related ThrombocytopeniaNCT05350956The First Affiliated Hospital of Zhengzhou University60
进行中（未招募）
3 期
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.Chemotherapy-Induced ThrombocytopeniaNCT05864014Jiangsu HengRui Medicine Co., Ltd.213
尚未招募
2 期
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaChemotherapy-Induced ThrombocytopeniaNCT05944211RenJi Hospital72
招募中
2 期
Herombopag for Chemotherapy-induced ThrombocytopeniaChemotherapy-induced ThrombocytopeniaHerombopagNCT05236582Institute of Hematology & Blood Diseases Hospital, China50